AMO chases contacts after Visx merger
This article was originally published in The Gray Sheet
Executive Summary
Advanced Medical Optics will seek acquisitions in contact lens arena - potentially competing with giants Ciba Vision, Bausch & Lomb and J&J/Vistakon. AMO inked a July pact to market CooperVision's hydrogel contact lenses in Europe and the Asia-Pacific under its Complete eye care line, with the lenses branded as Aquavision. The licensing deal allows AMO to test the waters "before we jump in," Mazzo says at First Albany Capital analyst conference Dec. 7. The firm expects its $1.27 bil. acquisition of Visx to close in Q1 2005...
You may also be interested in...
AMO Deciding Whether To Enter Contact Lens, Dry Eye Markets
Advanced Medical Optics will decide this year if it will make a long-term commitment in the contact lens sector
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.